Biomedical
The novel fusogenic peptides improve the delivery of therapeutics for ovarian cancer through their ability to enhance endosomal escape and delivery of bioactive therapeutics. Epithelial ovarian cancer is the 5th leading cancer among women, with a 49% five-year survival rate. Current treatment strategies for ovarian cancer include surgical removal, chemotherapy, and radiation; however, these treatments often prove ineffective or toxic…
Inventor: Angela Alexander-Bryant, Timothy Samec
Published: 12/6/2022
Biomedical
Clemson University and Emory University researchers have partnered up to uncover the efficacy that Ibrutinib can have in targeting and reversing the expression of cocaine addiction genes in human meso-cortico-limbic circuitry.
Inventor: Robert Anholt and
Trudy Mackay
Published: 10/26/2021
Biomedical
Clemson University researchers have developed a new family of modified small molecules that include bisbenzimidazole derivatives as antimicrobials and topoisomerase inhibitors.
Inventor: Dev Arya, Nihar Ranjan, Fenfei Leng
Published: 1/15/2021
Biotechnology
In order to fill the gaps in existing biomedical knowledge, Clemson University researchers have developed MOLIERE, which utilizes information from over 24.5 million historic documents including scientific papers, keywords, genes, proteins, diseases and diagnoses.
Inventor: Ilya Safro
Published: 10/30/2020
Biomedical
Clemson researchers have developed novel compounds that are active against trypanosomiasis and other parasitic infections, offering an avenue for dramatically improved treatment.
Inventor: Daniel Whitehead, Jim Morris
Published: 10/27/2020
